SEC · 2017 ANNUAL REPORT 1756 Bison Meadow Lane Heath, Texas 75032 This Annual Report is dated...
18
Transcript of SEC · 2017 ANNUAL REPORT 1756 Bison Meadow Lane Heath, Texas 75032 This Annual Report is dated...
![Page 1: SEC · 2017 ANNUAL REPORT 1756 Bison Meadow Lane Heath, Texas 75032 This Annual Report is dated April 23, 2018. BUSINESS Corporate Background and General Overview BioClonetics Immunotherapeutics,](https://reader034.fdocuments.in/reader034/viewer/2022052015/602cfdb43bf99e2a727caea8/html5/thumbnails/1.jpg)
![Page 2: SEC · 2017 ANNUAL REPORT 1756 Bison Meadow Lane Heath, Texas 75032 This Annual Report is dated April 23, 2018. BUSINESS Corporate Background and General Overview BioClonetics Immunotherapeutics,](https://reader034.fdocuments.in/reader034/viewer/2022052015/602cfdb43bf99e2a727caea8/html5/thumbnails/2.jpg)
![Page 3: SEC · 2017 ANNUAL REPORT 1756 Bison Meadow Lane Heath, Texas 75032 This Annual Report is dated April 23, 2018. BUSINESS Corporate Background and General Overview BioClonetics Immunotherapeutics,](https://reader034.fdocuments.in/reader034/viewer/2022052015/602cfdb43bf99e2a727caea8/html5/thumbnails/3.jpg)
![Page 4: SEC · 2017 ANNUAL REPORT 1756 Bison Meadow Lane Heath, Texas 75032 This Annual Report is dated April 23, 2018. BUSINESS Corporate Background and General Overview BioClonetics Immunotherapeutics,](https://reader034.fdocuments.in/reader034/viewer/2022052015/602cfdb43bf99e2a727caea8/html5/thumbnails/4.jpg)
![Page 5: SEC · 2017 ANNUAL REPORT 1756 Bison Meadow Lane Heath, Texas 75032 This Annual Report is dated April 23, 2018. BUSINESS Corporate Background and General Overview BioClonetics Immunotherapeutics,](https://reader034.fdocuments.in/reader034/viewer/2022052015/602cfdb43bf99e2a727caea8/html5/thumbnails/5.jpg)
![Page 6: SEC · 2017 ANNUAL REPORT 1756 Bison Meadow Lane Heath, Texas 75032 This Annual Report is dated April 23, 2018. BUSINESS Corporate Background and General Overview BioClonetics Immunotherapeutics,](https://reader034.fdocuments.in/reader034/viewer/2022052015/602cfdb43bf99e2a727caea8/html5/thumbnails/6.jpg)
![Page 7: SEC · 2017 ANNUAL REPORT 1756 Bison Meadow Lane Heath, Texas 75032 This Annual Report is dated April 23, 2018. BUSINESS Corporate Background and General Overview BioClonetics Immunotherapeutics,](https://reader034.fdocuments.in/reader034/viewer/2022052015/602cfdb43bf99e2a727caea8/html5/thumbnails/7.jpg)
![Page 8: SEC · 2017 ANNUAL REPORT 1756 Bison Meadow Lane Heath, Texas 75032 This Annual Report is dated April 23, 2018. BUSINESS Corporate Background and General Overview BioClonetics Immunotherapeutics,](https://reader034.fdocuments.in/reader034/viewer/2022052015/602cfdb43bf99e2a727caea8/html5/thumbnails/8.jpg)
![Page 9: SEC · 2017 ANNUAL REPORT 1756 Bison Meadow Lane Heath, Texas 75032 This Annual Report is dated April 23, 2018. BUSINESS Corporate Background and General Overview BioClonetics Immunotherapeutics,](https://reader034.fdocuments.in/reader034/viewer/2022052015/602cfdb43bf99e2a727caea8/html5/thumbnails/9.jpg)
![Page 10: SEC · 2017 ANNUAL REPORT 1756 Bison Meadow Lane Heath, Texas 75032 This Annual Report is dated April 23, 2018. BUSINESS Corporate Background and General Overview BioClonetics Immunotherapeutics,](https://reader034.fdocuments.in/reader034/viewer/2022052015/602cfdb43bf99e2a727caea8/html5/thumbnails/10.jpg)
![Page 11: SEC · 2017 ANNUAL REPORT 1756 Bison Meadow Lane Heath, Texas 75032 This Annual Report is dated April 23, 2018. BUSINESS Corporate Background and General Overview BioClonetics Immunotherapeutics,](https://reader034.fdocuments.in/reader034/viewer/2022052015/602cfdb43bf99e2a727caea8/html5/thumbnails/11.jpg)
SIGNATURE
Pursuant to the requirements of Sections 4(a)(6) and 4A of the Securities Act of 1933 and Regulation Crowdfunding (§ 227.100-503), the issuer certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form C and has duly caused this Form to be signed on its behalf by the duly authorized undersigned, on April 23, 2018. BioClonetics lmmunotherapeutics, Inc.
By /s/ Charles S. Cotropia
Title: Chief Executive Officer, President and Director
![Page 12: SEC · 2017 ANNUAL REPORT 1756 Bison Meadow Lane Heath, Texas 75032 This Annual Report is dated April 23, 2018. BUSINESS Corporate Background and General Overview BioClonetics Immunotherapeutics,](https://reader034.fdocuments.in/reader034/viewer/2022052015/602cfdb43bf99e2a727caea8/html5/thumbnails/12.jpg)
![Page 13: SEC · 2017 ANNUAL REPORT 1756 Bison Meadow Lane Heath, Texas 75032 This Annual Report is dated April 23, 2018. BUSINESS Corporate Background and General Overview BioClonetics Immunotherapeutics,](https://reader034.fdocuments.in/reader034/viewer/2022052015/602cfdb43bf99e2a727caea8/html5/thumbnails/13.jpg)
![Page 14: SEC · 2017 ANNUAL REPORT 1756 Bison Meadow Lane Heath, Texas 75032 This Annual Report is dated April 23, 2018. BUSINESS Corporate Background and General Overview BioClonetics Immunotherapeutics,](https://reader034.fdocuments.in/reader034/viewer/2022052015/602cfdb43bf99e2a727caea8/html5/thumbnails/14.jpg)
![Page 15: SEC · 2017 ANNUAL REPORT 1756 Bison Meadow Lane Heath, Texas 75032 This Annual Report is dated April 23, 2018. BUSINESS Corporate Background and General Overview BioClonetics Immunotherapeutics,](https://reader034.fdocuments.in/reader034/viewer/2022052015/602cfdb43bf99e2a727caea8/html5/thumbnails/15.jpg)
![Page 16: SEC · 2017 ANNUAL REPORT 1756 Bison Meadow Lane Heath, Texas 75032 This Annual Report is dated April 23, 2018. BUSINESS Corporate Background and General Overview BioClonetics Immunotherapeutics,](https://reader034.fdocuments.in/reader034/viewer/2022052015/602cfdb43bf99e2a727caea8/html5/thumbnails/16.jpg)
![Page 17: SEC · 2017 ANNUAL REPORT 1756 Bison Meadow Lane Heath, Texas 75032 This Annual Report is dated April 23, 2018. BUSINESS Corporate Background and General Overview BioClonetics Immunotherapeutics,](https://reader034.fdocuments.in/reader034/viewer/2022052015/602cfdb43bf99e2a727caea8/html5/thumbnails/17.jpg)
![Page 18: SEC · 2017 ANNUAL REPORT 1756 Bison Meadow Lane Heath, Texas 75032 This Annual Report is dated April 23, 2018. BUSINESS Corporate Background and General Overview BioClonetics Immunotherapeutics,](https://reader034.fdocuments.in/reader034/viewer/2022052015/602cfdb43bf99e2a727caea8/html5/thumbnails/18.jpg)